Abstract
Adenovirus makes extensive use of RNA splicing to produce a complex set of spliced mRNAs during virus replication. All transcription units, except pIX and IVa2, encode multiple alternatively spliced mRNAs. The accumulation of viral mRNAs is subjected to a temporal regulation, a mechanism that ensures that proteins that are needed at certain stages of the viral life cycle are produced. The complex interaction between host cell RNA splicing factors and viral regulatory elements has been studied intensely during the last decade. Such studies have begun to produce a picture of how adenovirus remodels the host cell RNA splicing machinery to orchestrate the shift from the early to the late profile of viral mRNA accumulation. Recent progress has to a large extent focused on the mechanisms regulating E1A and Ll alternative splicing. Here we will review the current knowledge of cis-acting sequence element, trans-acting factors and mechanisms controlling E1A and L1 alternative splicing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Axusjärvi G and Persson H (1981) Controls of RNA splicing and termination in the major late adenovirus transcription unit. Nature 292: 420–426
Akusjärvi G, Pettersson U and Roberts RI (1986) Structure and function of the adenovirus-2 genome. In: Doerfler W (ed) Adenovirus DNA: the viral genome and its expression. Martin Nijhoff Publishing, Oxford 8: 53–95
Aspegren A, Rabino C and Bridge E (1998) Organization of splicing factors in adenovirus-infected cells reflects changes in gene expression during the early to late phase transition. Exp Cell Res 245: 203–213
Berget SM, Moore C and Sharp PA (1977) Spliced segments at the 5’ terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci USA 74: 3171–3175
Berk AJ AND Sharp PA (1978) Structure of the adenovirus 2 early mRNAs. Cell 14: 695–711
E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter. J Virol 70:3844–3851
Bourgeois CF, Popielarz M, Hildwein G and Stévenin J (1999) Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5’ or 3’ splice site activation. Mol Cell Biol 19 7347–7356
Bridge E, Riedel KU, Johansson BM and Pettersson U (1996) Spliced exons of adenovirus late RNAs colocalize with snRNP in a specific nuclear domain. J Cell Biol 135: 303–314
Bridge E,Xia DX, Carmo-Fonseca M, Cardinali B, Lamond AI and Pettersson U (1995) Dynamic organization of splicing factors in adenovirus-infected cells. J Virol 69: 281–290
Brockmann D, Tries B and Esche H (1990) Isolation and characterization of novel adenovirus type 12 E1A mRNAs by cDNA PCR technique. Virology 179: 585–590
Bruni R and Roizman B (1996) Open reading frame P–A herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA. Proc Natl Acad Sci USA 93: 10423–10427
Bryant HE, Matthews DA, Wadd S, Scott JE, Kean J, Graham S, Russell WC and Clements JB (2000) Interaction between herpes simplex virus type 1 IE63 protein and cellular protein p32. J Virol 74: 11322–11328
Burd CG AND Dreyfuss G (1994) RNA binding specificity of hnRNP Al: significance of hnRNP Al high-affinity binding sites in pre-mRNA splicing. EMBO J 13: 11971204
Burge CB, Tuschl T and Sharp P (1998) Splicing of precursors to mRNAs by the spliceosome. In: Gesteland RF, Cech TR, Atkins JF (eds) The RNA world, Second edition. Cold Spring Harbor Press, Cold Spring Harbor NY, pp 525–560: 525–560
Caceres JF, Stamm S, Helfman DM and Krainer AR (1994) Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265: 1706–1709
Cavaloc Y, Bourgeois CF, Kister L and Stevenin J (1999) The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. RNA 5: 468–483
ChambonP (1977) Summary: The molecular biology of the eukaryotic genome is coming of age. Cold Spring Harbor Symposium Series, Vol. XLII, Cold Spring Harbor Press, Cold Spring Harbor NY, Vol. XLII: pp 1209–1234
ChebliK, GattoniR, SchmittP, HildweinG and SteveninJ (1989) The 216-
nucleotide intron of the E1A pre-mRNA contains a hairpin structure that permits utilization of unusually distant branch acceptors. Mol Cell Biol 9:4852–4861
ChenMR, YangJF, WuCW, MiddeldorpJM and ChenJY (1998) Physical association between the EBV protein EBNA-1 and P32/TAP/hyaluronectin. J Biomed Sci 5: 173–179
ChowLT and BrokerTR (1978) The spliced structures of adenovirus 2 fiber message and the other late mRNAs. Cell 15: 497–510
ChowLT, BrokerTR and LewisJB (1979) Complex splicing patterns of RNAs from the early regions of adenovirus-2. J Mol Biol 134: 265–303
ChowLT, GelinasRE, BrokerTR and RobertsRJ (1977) An amazing sequence arrangement at the 5’ ends of adenovirus 2 messenger RNA. Cell 12: 1–8
CroneDE and KeeneJD (1989) Viral transcription is necessary and sufficient for vesicular stomatitis virus to inhibit maturation of small nuclear ribonucleoproteins. J Virol 63: 4172–4180.
DauksaiteV and AkusjärviG (2002) Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing. J Biol Chem 277: 12579–12586
DelsertC, MorinN and KlessigDF (1989) cis-acting elements and a trans-acting factor affecting alternative splicing of adenovirus L1 transcripts. Mol Cell Biol 9: 4364–4371
DuncanPI, StojdlDF, MariusRM and BellJC (1997) In vivo regulation of alter- native pre-mRNA splicing by the Clkl protein kinase. Mol Cell Biol 17: 5996–6001
DunnAR and HassellJA (1977) A novel method to map transcripts: evidence for homology between an adenovirus mRNA and discrete multiple regions of the viral genome. Cell 12: 23–36
Estmer Nilsson C, Petersen-Mahrt S, Durot C, Shtrichman R, Krainer AR
KleinbergerT and AkusjärvI G (2001) The adenovirus E4–ORF4 splicing enhanc- er protein interacts with a subset of phosphorylated SR proteins. EMBO J 20: 864–871
FlintSJ, EnquistLW, KrugRM, RacanielloVR and SkalkaAM (2000) The
principles of Virology; Molecular Biology, Pathogenesis and Control. ASM Press, Washington, DC
FuXD (1995) The superfamily of arginine/serine-rich splicing factors. RNA 1: 663–680
Gama-CarvalhoM, KraussRD, ChiangL, ValcarcelJ, GreenMR and Carmo-
FonsecaM (1997) Targeting of U2AF65 to sites of active splicing in the nucleus. J Cell Biol 137: 975–987
GattoniR, ChebliK, HimmelspachM and StéveninJ (1991) Modulation of alter-
native splicing of adenoviral EIA transcripts: factors involved in the early-to-late transition. Genes Dev 5:1847–1858
GattoniR, SchmittP and StéveninJ (1988) In vitro splicing of adenovirus E1A
transcripts: characterization of novel reactions and of multiple branch points far from the 3’ splice site. Nucleic Acids Res 16:2389–2409
Ge H and Manley JL (1990) A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell 62: 25–34
Graveley BB (2000) Sorting out the complexity of SR protein functions. RNA 6: 11971211
Gut Jf, Lane WS and Fu XD (1994) A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 369: 678–682
Gustin KE and Imperiale MJ (1998) Encapsidation of viral DNA requires the adenovirus L1 52/55-kilodalton protein. J Virol 72: 7860–7870
Harper JE and Manley JL (1992) Multiple activities of the human splicing factor ASF. Gene Expr 2: 19–29
Himmelspach M, Cavaloc Y, Chebli K, Stévenin J and Gattoni R (1995) Titration
of serine/arginine (SR) splicing factors during adenoviral infection modulates ElA pre-mRNA alternative splicing. RNA 1:794–806
Hrimech M, Yao XJ, Branton PE and Cohen EA (2000) Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2 A. EMBO J 19: 3956–3967
Huang T-S, Estmer-Nilsson C, Punga T and Akusjärvi G (2002) Functional inacti-
vation of the SR family of splicing factors during a vaccinia virus infection. EMBO reports 3:1088–1093
Imperiale M, Akusjärvi G and Leppard K (1995) Post-transcriptional control of adenovirus gene expression. In: Doerfler W and Böhm P (eds) Current Topics in Microbiology and Immunology. Springer Verlag, Vol. 199/II, pp 139–171
Johnston JM, Anderson KP and Klessig DF (1985) Partial block to transcription of human adenovirus type 2 late genes in abortively infected monkey cells. J Virol 56: 378–385
KANOPKA A, MÜHLEMANN O AND AKUSJÄRVI G (1996) Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature, 381: 535–538
Kanopka A, Mühlemann O, Petersen-Mahrt S, Estmer C, Öhrmalm C and
Akusjärvi G (1998) Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature 393: 185–187
Kleinberger T and Shenk T (1993) Adenovirus E4orf4 protein binds to protein phosphatase-2 A, and the complex down regulates E1A-enhanced junB transcription. J Virol 67: 7556–7560
Klessig DF (1977) Two adenovirus mRNAs have a common 5’ terminal leader sequence encoded at least 10 kb upstream from their main coding regions. Cell 12: 9–21
Kornitzer D, Share R and Kleinberger T (2001) Adenovirus E4orf4 protein induces PP2A-dependent growth arrest in Saccharomyces cerevisiae and interacts with the anaphase-promoting complex/cyclosome. J Cell Biol 154: 331–344
Krainer AR, Conway GC and Kozak D (1990) The essential pre-mRNA splicing factor SF2 influences 5’ splice site selection by activating proximal sites. Cell 62: 35–42
Kreivi J-P and Akusjärvi G (1994) Regulation of adenovirus alternative RNA splicing at the level of commitment complex formation. Nucleic Acids Res 22: 332–337
Kreivi J-P, Zerivitz K and Akusjärvi G (1991) Sequences involved in the control of
adenovirus L alternative RNA splicing. Nucleic Acids Res 19:2379–2386
Larsson S, Kreivi J-P and Akusjärvi G (1991) Control of adenovirus alternative
RNA splicing: effect of viral DNA replication on splice site choice. Gene 107:219–227
Lerga A, Hallier M, Delva L, Orvain C, Gallais I, Marie J and Moreau-Gachelin
F (2001) Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem 276: 6807–6816
Lu X, Timchenko NA and Timchenko LT (1999) Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum Mol Genet 8: 53–60
Luo Y, Yu H and Peterlin BM (1994) Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J Virol 68: 3850–3856
Mandel JL (1989) Dystrophin: The gene and its product. Nature 339:584–586 Manley JL, Sharp PA and Gefter ML (1979) RNA synthesis in isolated nuclei:
identification and comparison of adenovirus 2 encoded transcripts synthesized in
vitro and vivo. J Mol Biol 135:171–197
Manley JL and Tacke R (1996) SR proteins and splicing control. Genes & Dev 10: 1569–1579
Marcellus RC, Lavoie JN, Boivin D, Shore GC, Ketner G and Branton PE (1998)
The early region 4 orf4 protein of human adenovirus type 5 induces p53- independent cell death by apoptosis. J Virol 72:7144–7153
Matthews DA and Russell WC (1998) Adenovirus core protein V interacts with p32-a protein which is associated with both the mitochondria and the nucleus. J Gen Virol 79: 1677–1685
Mayeda A and Krainer AR (1992) Regulation of alternative pre-mRNA splicing by hnRNP Al and splicing factor SF2. Cell 68: 365–375
Mermoud JE, COHEN PT and Lamond AI (1994) Regulation of mammalian spliceo-
some assembly by a protein phosphorylation mechanism. EMBO J 13:5679–5688 Misteli T (1999) RNA splicing: What has phosphorylation got to do with it? Curr
Biol 9:198–200
Molin M, Bouakas L, Berenjian S and Akusjärvi G (2002) Unscheduled expression
of capsid protein IIIa results in defects in adenovirus major late mRNA and protein expression. Virus Res 83 197–206
Muller U, Kleinberger T and Shenk T (1992) Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1. J Virol 66: 5867–5878
Mühlemann O, Kreivi J-P and Akusjärvi G (1995) Enhanced splicing of nonconsensus 3’ splice sites late during adenovirus infection. J Virol 69: 7324–7327
Mühlemann O, Yue BG, Petersen-Mahrt S and Akusjärvi G (2000) A novel type
of splicing enhancer regulating adenovirus pre-mRNA splicing. Mol Cell Biol 20: 2317–2325
Nevins JR and Wilson MC (1981) Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing. Nature 290: 113–118
Pallas DC, Shahrik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL and
Roberts TM (1990) Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2 A. Cell 60: 167–176
Perricaudet M, Akusjärvi G, Virtanen A and Pettersson U (1979) Structure of
two spliced mRNAs from the transforming region of hmna subgroup C adenoviruses. Nature 281:694–696
Petersen-Mahrt SK, Estmer C, Ohrmalm C, Matthews DA, Russell WC and
Akusjärvi G (1999) The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J 18: 1014–1024
Philips AV, Timchenko LT and Cooper TA (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280: 737–741
Pilder S, Moore M, Logan J and Shenk T (1986) The adenovirus E1B-55 K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol 6: 470–476
Popielarz M, Gattoni R and Stevenin J (1993) Contrasted cis-acting effects of downstream 5’ splice sites on the splicing of a retained intron: the adenoviral E1A pre-mRNA model. Nucleic Acids Res 21: 5144–5151
Prasad J, Colwill K, Pawson T and Manley JL (1999) The protein kinase Clk/Sty directly modulates SR protein activity: both hyper-and hypophosphorylation inhibit splicing. Mol Cell Biol 19: 6991–7000
Puvion-Dutilleul F, Bachellerie JP Visa N and Puvion E (1994) Rearrangements
of intranuclear structures involved in RNA processing in response to adenovirus infection. J Cell Sci 107:1457–1468
Schmitt P, Gattoni R, Keohavong P and Stévenin J (1987) Alternative splicing of E1A transcripts of adenovirus requires appropriate ionic conditions in vitro. Cell 50: 31–39
Screaton GR, Caceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG
Bell JI and Krainer AR (1995) Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 14: 43364349
Shtrichman R and Kleinberger T (1998) Adenovirus type 5 E4 open reading frame 4 protein induces apoptosis in transformed cells. J Virol 72: 2975–2982
Singh R, Valcarcel J and Green MR (1995) Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268: 1173–1176
Smith CWJ, Patton JG and Nadal-Ginard B (1989) Alternative splicing in the control of gene expression. Ann Rev Genet 23: 527–577
Soloway PD and Shenk T (1990) The adenovirus type 5 i-leader open reading frame functions in cis to reduce the half-life of Ll mRNAs. J Virol 64: 551–558
Spector DJ, Mcgrogan M and Raskas HJ (1978) Regulation of the appearance of cytoplasmic RNAs from region 1 of the adenovirus 2 genome. J Mol Biol 126: 395–414
Stark JM, Bazett-Jones DP, Herfort M and Roth MB (1998) SR proteins are
sufficient for exon bridging across an intron. Proc Natl Acad Sci USA 95:2163–2168 Stephens C and Harlow E (1987) Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins. EMBO J 6: 2027–2035
Stewart PL and Burnett RM (1995) Adenovirus structure by X-ray crystallography and electron microscopy. In: Doerfler W and Böhm P (eds) Current Topics in Microbiology and Immunology. Springer Verlag, Berlin, Vol. 199/I, pp 25–38
Svensson C and Akusjärvi G (1986) Defective RNA splicing in the absence of adenovirus-associated RNAI. Proc Natl Acad Sci USA 83: 4690–4694
Svensson C, Pettersson U and Akusjärvi G (1983) Splicing of adenovirus 2 early region 1 A mRNAs is non-sequential. J Mol Biol 165: 475–495
Symington JS, Lucher LA, Brackmann KH,Virtanen A, Pettersson U and Green
M (1986) Biosynthesis of adenovirus type 2 i-leader protein. J Virol 57: 848–856
Tacke R and MANLEY JL (1995) The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J 14: 3540–3551
Tange TO, Jensen TH and Kjems J (1996) In vitro interaction between human immunodeficiency virus type 1 rev protein and splicing factor ASF/SF2-associated protein, p32.1 Biol Chem 271: 10066–10072
Thomas GP and Mathews MB (1980) DNA replication and the early to late transition in adenovirus infection. Cell 22: 523–532
Ulfendahl PJ, Kreivi JP and Akusjärvi G (1989) Role of the branch site/3’-splice site region in adenovirus-2 E1A pre-mRNA alternative splicing: evidence for 5’-and 3’-splice site co-operation. Nucleic Acids Res 17: 925–938
Ulfendahl PJ, Linder S, Kreivi JP, Nordqvist K, Sevensson C, Hultberg H and
Akusjärvi G (1987) A novel adenovirus-2 E1A mRNA encoding a protein with transcription activation properties. EMBO J 6: 2037–2044
Van Ormondt H,Maat J and Dijkema R (1980) Comparison of nucleotide sequences of the early Ela regions for subgroups A, B and C of human adenoviruses. Gene 12: 63–76
Walter G, Ruediger R, Slaughter C and Mumby M (1990) Association of protein phosphatase 2 A with polyoma virus medium tumor antigen. Proc Natl Acad Sci USA 87: 2521–2525
Wang J and Manley JL (1995) Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1: 335–346
Wang YL, Finan JE, Middeldorp JM and Hayward SD (1997) P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. Virology 236: 18–29
Wilson MC and Darnell JE, Jr (1981) Control of messenger RNA concentration by differential cytoplasmic half-life. Adenovirus messenger RNAs from transcription units 1 A and 1B. J Mol Biol 148: 231–251
Wu JY and Maniatis T (1993) Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75: 1061–1070
Yang X, Bani MR, Lu SJ, Rowan S, Ben-David Y and Chabot B (1994) The Al and
AlB proteins of heterogeneous nuclear ribonucleoparticles modulate 5’ splice site selection in vivo. Proc Natl Acad Sci USA 91:6924–6928
Yu L, Loewenstein PM, Zhang Z and Green M (1995) In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP. J Virol 69: 3017–3023
Yue BG and Akusjärvi G (1999) A downstream splicing enhancer is essential for in vitro pre-mRNA splicing. FEBS Lett 451: 10–14
Yueh A and Schneider RJ (2000) Translation by ribosome shunting on adenovirus and hsp70 mRNAs facilitated by complementarity to 18S rRNA. Genes Dev 14: 414–421
Zahler AM, Neugebauer KM, Lane WS and Roth MB (1993) Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260: 219–222
Zamore PD, Patton JG and Green MR (1992) Cloning and domain structure of the mammalian splicing factor U2AF. Nature 355: 609–614
Zerivitz K, Kreivi J-P and Akusjärvi G (1992) Evidence for a HeLa cell splicing activity that is necessary for activation of a regualted adenovirus 3’ splice site. Nucleic Acids Res 20: 3955–3961
Zhang WJ and Wu JY (1996) Functional properties of p54, a novel SR protein active in constitutive and alternative splicing. Mol Cell Biol 16: 5400–5408
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Akusjärvi, G., Stévenin, J. (2003). Remodelling of the Host Cell RNA Splicing Machinery During an Adenovirus Infection. In: Doerfler, W., Böhm, P. (eds) Adenoviruses: Model and Vectors in Virus-Host Interactions. Current Topics in Microbiology and Immunology, vol 272. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05597-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-05597-7_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-05517-1
Online ISBN: 978-3-662-05597-7
eBook Packages: Springer Book Archive